535 related articles for article (PubMed ID: 17708554)
21. The role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in distinguishing pancreatic cystic lesions.
Moparty B; Logroño R; Nealon WH; Waxman I; Raju GS; Pasricha PJ; Bhutani MS
Diagn Cytopathol; 2007 Jan; 35(1):18-25. PubMed ID: 17173300
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
[TBL] [Abstract][Full Text] [Related]
23. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
24. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
25. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
26. Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors.
Yamasaki H; Ikeda S; Okajima M; Miura Y; Asahara T; Kohno N; Shimamoto F
Int J Oncol; 2004 Jan; 24(1):107-13. PubMed ID: 14654947
[TBL] [Abstract][Full Text] [Related]
27. MUC1, MUC2 and MUC5AC expressions in cardiac myxoma.
Chu PH; Jung SM; Yeh TS; Lin HC; Chu JJ
Virchows Arch; 2005 Jan; 446(1):52-5. PubMed ID: 15568157
[TBL] [Abstract][Full Text] [Related]
28. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
29. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.
Pinto-de-Sousa J; Reis CA; David L; Pimenta A; Cardoso-de-Oliveira M
Virchows Arch; 2004 Mar; 444(3):224-30. PubMed ID: 14758553
[TBL] [Abstract][Full Text] [Related]
30. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.
Kesari MV; Gaopande VL; Joshi AR; Babanagare SV; Gogate BP; Khadilkar AV
Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of mucinous nonneoplastic cysts of the pancreas.
Nadig SN; Pedrosa I; Goldsmith JD; Callery MP; Vollmer CM
Pancreas; 2012 Apr; 41(3):441-6. PubMed ID: 22015974
[TBL] [Abstract][Full Text] [Related]
34. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor.
Yonezawa S; Horinouchi M; Osako M; Kubo M; Takao S; Arimura Y; Nagata K; Tanaka S; Sakoda K; Aikou T; Sato E
Pathol Int; 1999 Jan; 49(1):45-54. PubMed ID: 10227724
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts.
Attasaranya S; Pais S; LeBlanc J; McHenry L; Sherman S; DeWitt JM
JOP; 2007 Sep; 8(5):553-63. PubMed ID: 17873459
[TBL] [Abstract][Full Text] [Related]
36. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
[TBL] [Abstract][Full Text] [Related]
37. Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.
Ho JJ; Han SW; Pan PL; Deng G; Kuan SF; Kim YS
Int J Oncol; 2003 Feb; 22(2):273-9. PubMed ID: 12527922
[TBL] [Abstract][Full Text] [Related]
38. Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.
Nishigami T; Onodera M; Torii I; Sato A; Tao LH; Kushima R; Kakuno A; Kishimoto M; Katsuyama E; Fujimori T; Hirano H; Satake M; Kuroda N; Nishiguchi S; Fujimoto J; Tsujimura T
Pancreas; 2009 Jul; 38(5):558-64. PubMed ID: 19287335
[TBL] [Abstract][Full Text] [Related]
39. Molecular profile of apomucin and p53 protein as predictors of malignancy in intraductal papillary mucinous neoplasms of the pancreas.
Mizumoto M; Honjo G; Kobashi Y; Awane M; Matsusue S
Hepatogastroenterology; 2011; 58(110-111):1791-5. PubMed ID: 22086702
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]